Ambroxol is a medicine used to help clear mucus from the airways. It helps loosen thick mucus, making it easier to cough up. It's often used to treat coughs and congestion, especially those caused by colds or bronchitis.
Every report comes from a Lived member, sent anonymously.
Have you tried Ambroxol for Cough?
Ambroxol is a mucus-thinning medicine, known as an expectorant, sold in many countries under brand names such as Mucosolvan and Lasolvan. It is used for coughs and chest conditions in which thick mucus is hard to clear, such as acute bronchitis and some long-term lung diseases. Lozenge versions are used for short-term relief of a sore throat, and in some countries hospitals give an injectable form to premature and newborn babies with breathing problems. Ambroxol is not approved by the US Food and Drug Administration (FDA), and no finished ambroxol medicine is sold in US pharmacies. Americans usually come across it while traveling, in products bought abroad or online, or in news about research. Many products overseas are sold without a prescription, and some combine ambroxol with other active ingredients, so it is worth reading the label closely. Researchers are also studying ambroxol, at doses many times higher than those used for coughs, for Gaucher disease (an inherited condition in which certain fats build up inside cells) and for Parkinson disease linked to changes in the GBA1 gene (the gene that carries instructions for an enzyme called glucocerebrosidase). This use is experimental. It has not been shown to slow Parkinson disease or to replace standard Gaucher treatment.
Ambroxol is formed in the body from an older cough medicine, bromhexine, and acts on the airway lining in several ways. It makes mucus thinner and less sticky, encourages the tiny hair-like cilia that line the airways to sweep mucus upward, and increases surfactant, a natural substance that coats the small air sacs and helps mucus move. The aim is to make coughing more productive, not to stop the cough. Ambroxol also blocks sodium channels on nerve endings, which gives it a mild numbing effect. That is why a lozenge can briefly ease sore throat pain, and why some people notice a numb mouth or throat. At very high doses, ambroxol acts as a chaperone for glucocerebrosidase, an enzyme that breaks down certain fats inside cells. In people with GBA1 gene changes, this enzyme is often misfolded, and ambroxol helps more of it reach the part of the cell where it does its work. This is the reason for the Parkinson and Gaucher research. Raising enzyme levels, however, has not yet been shown to change how either disease progresses.
For mucus, adults usually take ambroxol by mouth as 30 mg tablets, typically one tablet three times a day; some labels allow two tablets twice a day instead. Tablets can be taken with or without food and are swallowed whole with plenty of liquid. Syrups and drops are used for children at lower amounts based on age, and ambroxol is not recommended for children under 2 without medical advice. Sore throat lozenges contain a smaller amount, commonly 20 mg, and are dissolved slowly in the mouth. Strengths, combinations and directions vary by country and product, so follow the package or prescriber for the exact product in hand. The doses studied for Parkinson and Gaucher disease, roughly 1,000 to 1,800 mg a day, are more than ten times the usual cough dose. They are used in clinical trials and specialist care, not for self-treatment.
Ambroxol is usually well tolerated. Nausea is the most common side effect of tablets and syrups; indigestion, stomach pain, vomiting and diarrhea are less common. Lozenges and sprays can change taste and cause a numb or dry mouth or throat, which usually fades after use. Digestive side effects were more frequent in the high-dose research trials. Allergic reactions such as rash, hives and itching are rare. After a European safety review, all ambroxol products now carry a warning about rare but severe skin reactions, including Stevens-Johnson syndrome, a dangerous reaction that causes blistering and peeling of the skin and the lining of the mouth and eyes. Stop ambroxol and contact a doctor right away if a rash spreads or blisters, or if sores appear in the mouth, eyes, nose or genitals. Severe allergic reactions (anaphylaxis) have also been reported. Swelling of the lips, tongue or throat, trouble breathing, or fainting after a dose is an emergency: call 911.
Avoid taking ambroxol at the same time as a cough suppressant, such as dextromethorphan or codeine. Loosening mucus while suppressing the cough that clears it can let secretions build up in the airways. Combination cold products may already contain other active ingredients, so check the label before adding another cough or cold medicine. Do not use ambroxol after an allergic reaction to it or to bromhexine, which the body converts into ambroxol. Product labels advise avoiding ambroxol in the first three months of pregnancy, because it crosses the placenta, and generally recommend against it while breastfeeding, because it passes into breast milk. Labels also advise caution for people with stomach ulcers, and some liquid forms contain sugars that people with rare inherited sugar intolerances should avoid. Products bought overseas or online have not been reviewed by the FDA, and their ingredients and strengths may differ from what a US clinician expects. Bring the package to any appointment so the care team can see exactly what it contains.
For a mucus-heavy cough, the hope is that phlegm becomes easier to bring up within a few days. The evidence behind this is modest. European regulators who reviewed decades of studies found some positive results but many weaknesses in how the studies were done, and a year-long trial in chronic obstructive pulmonary disease (COPD) found that ambroxol did not reduce flare-ups overall compared with a placebo. Many coughs from colds and bronchitis also improve on their own, which makes the effect of any single medicine hard to judge. Sore throat lozenges act quickly but modestly. In trials, they eased pain a little more than plain mint lozenges over the first three hours, and whether they help beyond that is unclear. Ambroxol is meant for short courses. See a doctor if the cough gets worse or has not improved after 4 to 5 days. For Parkinson disease, the research picture is still forming. A small 2025 trial in people with Parkinson disease dementia found high-dose ambroxol safe and able to raise enzyme levels, but it did not improve thinking or memory. A larger trial, ASPro-PD, is testing whether two years of high-dose ambroxol slows Parkinson progression, and its results are not yet available. In Gaucher disease, small studies have reported variable responses, and the quality of that evidence is low.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share your experience taking Ambroxol, what you've noticed, or ask the community a question.